203780KR market ClosedUS market —
TIGER 미국나스닥바이오
Undervaluation
-0.94%
Premium
ETF price
₩33,930
Close
iNAV estimate
₩33,615
Trading 0.94% above the ETF's fair value (iNAV)
FX rate ₩1,324.10Anchor date 2026-10-23
Constituents
Loading estimates…
This page sets an iNAV estimate for TIGER 미국나스닥바이오 against its Korean market quote to show the premium or discount. The guide explains how the estimate is built and where it falls short, and the fund's reference facts follow below.
Fund details
- Underlying index
- NASDAQ Biotechnology 지수(시장가격지수)
- Manager
- Mirae Asset
- Expense ratio
- 0.30%
- Replication
- Physical (passive)
- Currency hedge
- Unhedged
- Listing date
- 2014-08-27
- Creation unit
- 20,000